Yahoo Finance • 3 hours ago
Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers Squibb announced a development in its Alzheimer’s program: its experimental drug, BMS-986446, received Fast Track d... Full story
Yahoo Finance • 21 hours ago
Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 22 hours ago
Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • yesterday
Bristol-Myers Squibb (BMY) on Friday agreed to acquire privately-held ribonucleic acid medication ma PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • yesterday
BMS and NCPA to address cardiovascular disease and enhance patient care coordination with specialized training in rural Alabama, Arkansas, Kentucky, Louisiana, Mississippi, and Missouri pharmacies Originally published on NCPA.org NORTHAM... Full story
Yahoo Finance • yesterday
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further strengthens BMS’s industry-leading ce... Full story
Yahoo Finance • 2 days ago
Thinking about what to do with Bristol-Myers Squibb stock? You are certainly not alone. With shares closing recently at $44.54, there has been plenty to talk about, especially as the stock has faced some turbulence throughout 2025. Over th... Full story
Yahoo Finance • 4 days ago
Worawith Ounpeng MapLight Therapeutics (MPLT [https://seekingalpha.com/symbol/MPLT]), whose lead candidate ML-007C-MA could potentially rival Bristol Myers’ (BMY [https://seekingalpha.com/symbol/BMY]) recently approved antipsychotic Coben... Full story
Yahoo Finance • 4 days ago
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Bristol-Myers Squibb Company (N... Full story
Yahoo Finance • 4 days ago
In recent trading, shares of TMC The Metals Co Inc (Symbol: TMC) have crossed above the average analyst 12-month target price of $7.69, changing hands for $7.72/share. When a stock reaches the target an analyst has set, the analyst logica... Full story
Yahoo Finance • 5 days ago
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Plug Power Inc. 155,000,553 4.58 3.85 3.8888 +0.0788 Advanced Micro Devi... Full story
Yahoo Finance • 6 days ago
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now.Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks Bristol-Myers Squibb Company (NYSE:BMY) is a... Full story
Yahoo Finance • 6 days ago
[Pfizer HQ in New York City] georgeclerk What's the most attractive Big Pharma stock right now? We asked Seeking Alpha analysts The Value Portfolio [https://seekingalpha.com/author/the-value-portfolio] and ALLKA Research [https://seeking... Full story
Yahoo Finance • 7 days ago
[President Trump Delivers An Announcement From The Oval Office] Win McNamee/Getty Images News The world’s biggest pharma companies recorded their best weekly performance in years on Friday after Pfizer (NYSE:PFE [https://seekingalpha.com/... Full story
Yahoo Finance • 7 days ago
Bristol Myers Squibb recently announced its adoption of Veeva Systems' Vault CRM, underscoring Veeva’s growing presence in life sciences cloud software among top biopharma companies worldwide. This trend highlights a significant shift towa... Full story
Yahoo Finance • 8 days ago
Bristol-Myers Squibb Company (NYSE:BMY) is one of the most undervalued stocks to buy and hold for 5 years. On October 1, Bristol-Myers Squibb, Takeda Pharmaceuticals (NYSE:TAK), and Astex Pharmaceuticals agreed to collaborate and pool prop... Full story
Yahoo Finance • 9 days ago
Bristol-Myers Squibb announced that its investigational anti-tau antibody BMS-986446, aimed at early Alzheimer's disease, received Fast Track Designation from the FDA, a regulatory milestone intended to expedite the drug's development and... Full story
Yahoo Finance • 9 days ago
This article first appeared on GuruFocus. Bristol Myers Squibb (NYSE:BMY) just got a boost in its Alzheimer's program after the FDA granted Fast Track designation to its experimental drug BMS-986446, now in phase 2 testing for patients in... Full story
Yahoo Finance • 9 days ago
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top picks for a retirement portfolio. Bristol-Myers Squibb Company (NYSE:BMY) reported on September 23 that its Phase 3 EXCALIBER-RRMM trial using iberdomide combined with daratumumab... Full story
Yahoo Finance • 10 days ago
With significant upside potential, Bristol-Myers Squibb Company (NYSE:BMY) secures a spot on our list of the 20 NYSE Stocks with the Lowest P/E Ratios.Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Direc... Full story